Addex Therapeutics
Clinical trials sponsored by Addex Therapeutics, explained in plain language.
Now part of
Addex Therapeutics Ltd
ADXN
NASDAQ
Biopharma developing allosteric modulators for neurological disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.